NRG-LU002/ Maintenance Systemic Therapy/ Yuhchyau Chen
Research Question:
How well does maintenance chemotherapy treat patients with stage IV non-small cell
lung cancer?
Basic Study Information
Purpose:
This randomized phase II/III trial studies how well giving maintenance chemotherapy
with or without local consolidation therapy works in treating patients with stage
IV non-small cell lung cancer. Drugs used in maintenance chemotherapy, such as docetaxel,
pemetrexed disodium, erlotinib hydrochloride, and gemcitabine work in different ways
to stop the growth of tumor cells, either by killing the cells, by stopping them from
dividing, or by stopping them from spreading. Local consolidation therapy such as
radiation/stereotactic body radiation or surgery may kill cancer cells left after
initial treatment. Giving maintenance chemotherapy and local consolidation therapy
together may work better than maintenance chemotherapy alone in treating patients
with stage IV non-small cell lung cancer.
Location: University of Rochester
Lead Researcher (Principal Investigator)
Lead Researcher:
Michael Milano
Study Contact Information
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search